ArticleFrontiers in immunology2025

Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.

Ying He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.